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Abstract
The Hippo signalling pathway restricts cell proliferation in animal tissues by inhibiting Yes-
associated protein (YAP or YAP1) and Transcriptional Activator with a PDZ domain (TAZ or
WW-domain–containing transcriptional activator [WWTR1]), coactivators of the Scalloped
(Sd or TEAD) DNA-binding transcription factor. Drosophila has a single YAP/TAZ homolog
named Yorkie (Yki) that is regulated by Hippo pathway signalling in response to epithelial
polarity and tissue mechanics during development. Here, we show that Yki translocates to
the nucleus to drive Sd-mediated cell proliferation in the ovarian follicle cell epithelium in
response to mechanical stretching caused by the growth of the germline. Importantly,
mechanically induced Yki nuclear localisation also requires nutritionally induced insulin/insu-
lin-like growth factor 1 (IGF-1) signalling (IIS) via phosphatidyl inositol-3-kinase (PI3K),
phosphoinositide-dependent kinase 1 (PDK1 or PDPK1), and protein kinase B (Akt or PKB)
in the follicular epithelium. We find similar results in the developing Drosophila wing, where
Yki becomes nuclear in the mechanically stretched cells of the wing pouch during larval
feeding, which induces IIS, but translocates to the cytoplasm upon cessation of feeding in
the third instar stage. Inactivating Akt prevents nuclear Yki localisation in the wing disc,
while ectopic activation of the insulin receptor, PI3K, or Akt/PKB is sufficient to maintain
nuclear Yki in mechanically stimulated cells of the wing pouch even after feeding ceases.
Finally, IIS also promotes YAP nuclear localisation in response to mechanical cues in mam-
malian skin epithelia. Thus, the Hippo pathway has a physiological function as an integrator
of epithelial cell polarity, tissue mechanics, and nutritional cues to control cell proliferation
and tissue growth in both Drosophila and mammals.
Introduction
The growth of animal tissues is known to depend on nutritionally induced circulating hor-
mones of the insulin/insulin-like growth factor 1 (IGF-1) family [1–3]. In addition, tissue
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growth can be mechanically induced via the Hippo signalling pathway [4–8]. How these two
mechanisms of tissue growth control are integrated during animal development remains
unclear. The fruit fly Drosophila offers a tractable model system to explore how insulin/IGF-1
signalling (IIS) and the Hippo pathway interact to influence cell proliferation in multiple epi-
thelial tissues during development. In Drosophila oogenesis, the developing oocyte in each egg
chamber is fed cytoplasm by endoreplicating germline nurse cells that grow enormously in
size by cell growth without cell division [9–13]. The somatic follicle cell epithelium that sur-
rounds the germline grows by coordinated cell growth and cell division—cell proliferation—to
precisely encapsulate each egg chamber during early stages of oogenesis (stages 1–7) [14]. Pro-
liferation of follicle cells is thought to occur in response to mechanical stretching caused by the
growth of the underlying germline [15, 16]. Furthermore, growth of the entire egg chamber is
known to depend on adequate nutrient intake by the adult female [17]. After fertilisation of
the egg, embryogenesis proceeds within the eggshell without the need for feeding or growth.
At the end of embryogenesis, the hatching larvae is able to feed and grow via a similar subdivi-
sion of tissues into those growing without cell division (the endoreplicating larval tissues) and
those growing by cell proliferation (the mitotic ‘imaginal discs’ that give rise to the future adult
body or ‘imago’) [11, 12, 18]. The growth rate of the entire larva, including both endoreplicat-
ing and proliferating tissues, once again depends upon nutritional intake and thus contributes
to the determination of adult body size [1, 2, 19].
The IIS pathway was found to be induced by nutritional cues in Drosophila [1–3, 20–23].
Nutrient intake stimulates production of circulating Drosophila insulin-like peptides (Dilps),
which activate the insulin/IGF-1 receptor (InR), leading to the recruitment of the phosphatidyl
inositol-3-kinase (PI3K—composed of two subunits, p60 and p110), which coverts phosphati-
dyl inositol phosphate (PIP)2 to PIP3 at the plasma membrane of signal-receiving cells (a pro-
cess antagonised by the phosphatase and tensin homolog PTEN) [3, 20–30]. Induction of PIP3
leads to the recruitment of two Pleckstrin Homology (PH)-domain–containing kinases, phos-
phoinositide-dependent protein kinase 1 (PDK1) and Akt (also called protein kinase B [PKB]),
enabling PDK1 to phosphorylate Akt, which is then responsible for signal transduction [31–
37] and tissue growth control [38–41].
One important downstream effector of Akt is the Target of Rapamycin (TOR) complex 1
(TORC1), which promotes cell growth by inducing translation via Ribosomal protein S6
kinase (S6K) [39, 42, 43] and inactivating the translational inhibitor, Elongation initiating fac-
tor 4E binding protein (4E-BP) [43, 44]. TORC1 also induces ribosome biogenesis via the
RNA Polymerase (Pol) II transcription factors Myc [45–49] and DNA replication element
binding factor (DREF) [50] and the RNA Pol I activators Transcription intermediary factor
1A (TIF1A/Rrn3) [51, 52] and TIF1B/SL1-Upstream binding factor (UBF) [53], as well as by
inactivating the RNA Pol III inhibitor Maf1 [54, 55]. TORC1 is composed of the TOR kinase,
Raptor, and Lst8 subunits [56–59] and is activated by Ras-homolog enriched in the brain
(Rheb) GTPase [60–62] at the lysosome [63, 64] and inhibited by the Tuberous Sclerosis Com-
plex TSC1/2 GTPase-activating proteins (GAPs) [65–67] and the 40-kDa proline-rich Akt sub-
strate (PRAS40) [68–70]. Akt appears to activate TORC1 by phosphorylating TSC2 to displace
it from the lysosome [71, 72], although mutation of two Akt phosphorylation sites in TSC2
does not affect growth in Drosophila [73], suggesting that other Akt targets, such as PRAS40,
may compensate. Importantly, a negative feedback loop operates in which TORC1 activation
promotes cell growth but also functions to reduce phosphorylation and activation of Akt itself
[74, 75].
Another target of Akt is the transcription factor Forkhead box O (FOXO), which, upon IIS
activation, becomes phosphorylated by Akt to induce its retention in the cytoplasm [76–78].
Drosophila foxo mutants are viable and normally sized, but foxo is required for complete
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suppression of tissue growth upon reduced insulin/IGF-1–PI3K–Akt signalling, which sends
FOXO to the nucleus to inhibit cell proliferation and promote apoptosis [79, 80]. Thus, Akt
can act independently of the TORC1 complex to control cell proliferation rather than cell
growth, raising the question of whether additional Akt substrates may exist that contribute to
the control of tissue growth by the IIS pathway in proliferating tissues. The importance of this
question is underscored by the fact that activation of PI3K–Akt signalling (in PI3K catalytic
subunit alpha [PIK3CA] constitutively active mutant or in PTEN inactivating mutant tumours)
is a widespread cause of malignant human cancer, while activation of TORC1 (in TSC1 or
TSC2 mutant tumours) causes benign hamartomas [75, 81].
The Hippo signalling pathway was discovered by Drosophila genetics to restrict the rate of
cell proliferation and final tissue size in developing wing and eye imaginal discs but does not
affect cell growth in endoreplicating tissues [4–6]. The upstream kinase Hippo (Hpo) activates
the downstream kinase Warts (Wts), which then directly inhibits the nuclear localisation of
Yorkie (Yki), a transcriptional coactivator for Scalloped (Sd)/TEA domain (TEAD) DNA-
binding proteins [82–84]. In mutants for hpo or wts, Yki translocates to the nucleus to switch
Sd/TEAD from a repressor to an activator, which then drives cell proliferation and tissue
growth in the developing wing and eye imaginal discs [83–86]. When mutant clones for yki are
induced in the wing disc, cell proliferation is inhibited, and cells are eliminated by apoptosis
[82, 87]. These dramatic phenotypes strongly suggest that the Hippo pathway might have a
physiological role in tissue growth control in proliferating tissues, but it is still unclear how
dynamic regulation of Yki nuclear localisation is controlled as tissues initiate or arrest their
proliferation during development.
A physiological role for the Hippo pathway as a sensor of mechanical stress and strain in
vivo was recently identified in Drosophila [88, 89]. Here, we explore how mechanical regula-
tion of Hippo pathway integrates with nutritional control of tissue growth via the IIS pathway
in the ovarian follicle cell epithelium and wing imaginal disc. Previous work indicated that
genetic alteration of IIS can influence Hippo pathway signalling, but the physiological rele-
vance of this observation and the molecular mechanisms responsible are still not fully under-
stood [90]. Here, we propose that insulin/IGF-1 act via Akt to inhibit Hippo pathway
signalling and promote nuclear localisation of Yki in response to mechanical stress and strain.
In the follicle cell epithelium, Yki responds primarily to mechanical strain driven by growth of
the germline (itself insulin/IGF-1– and TORC1-dependent) but also requires PI3K–Akt signal-
ling in follicle cells. In the wing imaginal disc, Yki responds to Fat–Dachsous signalling [4–8]
and mechanical stress in columnar cells [89, 91–94], as well as to mechanical strain in flattened
peripodial cells [88, 95], and we uncover an additional physiological regulation by nutritionally
regulated IIS via PI3K–Akt. We further confirm a recent report that TORC1 is not required in
the wing disc for nuclear localisation of Yki and that loss of TORC1 in fact drives Yki to the
nucleus [96], which we attribute to feedback effects on PI3K–Akt. Finally, we confirm our
findings in the mammalian skin epithelium, an example of a tissue in which both IIS
and mechanically regulated Yes-associated protein (YAP) are crucial to promote cell
proliferation.
Results
We first examined early Drosophila oogenesis, where growth of the germline was shown to
mechanically induce proliferation of surrounding follicle cells during stages 2–6 [15, 16]. We
find that expression of the Yki reporter gene expanded.lacZ (ex.lacZ) is elevated and that green
fluorescent protein (GFP)-tagged Yki localises to the nucleus in proliferating follicle cells of
early-stage egg chambers (Fig 1A and 1B and S1 Fig). Since ex.lacZ suffers from perdurance of
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Fig 1. Yki localises to the nucleus to drive stretch-induced follicle cell proliferation in Drosophila egg chambers.
A) Expression of the Yki–Sd reporter gene ex.lacZ in early egg chambers is revealed by the pattern of nuclear beta-
galactosidase immunostaining. Note that ex.lacZ is expressed during the stages in which mechanical stretch drives
follicle cell proliferation. B) Expression and subcellular localisation of a Yki–GFP knockin line in early egg chambers
reveals nuclear localisation of endogenous Yki during the stages of stretch-induced follicle cell proliferation.
Quantification of the nuclear/cytoplasmic ratio of Yki–GFP is shown on the right (n> 30 per genotype; t test
p< 0.05). See supplementary file S1_Data.xlsx for underlying data. C) Mitotic cells (pH3+) in the follicle cell
epithelium are reduced upon expression of Yki–RNAi or Sd–RNAi. Numbers of follicle cells are reduced by both Yki–
RNAi or Sd–RNAi, more weakly in the latter case. The Yki–RNAi phenotype is so strong that germ line cells are often
affected by insufficiency in follicle cell numbers. Follicle cell fate, marked by expression of Eya, is not affected. The
Physiological regulation of the Hippo pathway during tissue growth
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the lacZ-encoded beta-galactosidase protein, which can obscure effects over short timescales,
we chose to focus on Yki–GFP localisation as a more dynamic readout. We noticed that Yki
nuclear localisation exhibited some female-to-female variation, evident in the quantification of
the nuclear/cytoplasmic ratio of wild-type females (Fig 1B). We wondered whether this varia-
tion might relate to the growth rate of the egg chambers. To test this notion, we arrested germ-
line growth beyond stage 4 using Ovo dominant (OvoD) mutants, which we find prevents
mechanical stretching of follicle cells and inhibits Yki nuclear localisation (Fig 1B). Note that
in OvoD egg chambers, some nuclear Yki is still detectable prior to stage 4, but after stage 4,
Yki is strongly cytoplasmic, as shown in the quantification (Fig 1B). Yki is known to promote
follicle stem cell maintenance [97] and polar cell fate [98], but whether Yki is also involved in
stretch-induced cell proliferation in follicle cells has not been explored. We find that Yki is
essential for normal follicle cell proliferation because silencing of yki expression specifically in
follicle cells by trafficjam.Gal4 (tj.Gal4)-driven transgenic Upstream activator sequence (UAS).
yki-RNA interference (RNAi) reduces the number of phospho-Histone-H3–positive mitotic
cells in each ovariole and profoundly disrupts oogenesis without affecting cell fate specification
of follicle cells (marked by expression of Eyes Absent [Eya] and Broad) or follicle cell apoptosis
(marked by Drosophila Death Caspase 1 [Dcp1] staining) (Fig 1C and 1D). Note that the insuf-
ficient number of follicle cells in the absence of Yki leads to germline apoptosis (Dcp1-positive)
[16] (Fig 1D). Silencing of Sd by expression of UAS.sd-RNAi causes a milder phenotype, reduc-
ing follicle cell proliferation without disrupting germline growth during early stages (Fig 1C
and 1D and S2 Fig). These results show that Yki subcellular localisation is dynamically pat-
terned during early proliferative follicle cell development, becoming nuclear-localised in order
for the Yki–Sd transcription factor to promote follicle cell proliferation during early egg cham-
ber growth.
The fact that the loss of Sd causes a weaker phenotype than loss of Yki is expected because
Sd acts as default repressor such that loss of Yki prevents activation and leads to constitutive
repression of Yki–Sd target genes, while loss of Sd prevents either activation or repression of
target genes [86, 99]. Nevertheless, we sought to confirm that our UAS.sd-RNAi line was
indeed causing a full loss of Sd function. Since Sd acts as a direct binding partner for Yki in the
nucleus, it promotes Yki nuclear localisation [100–102]. We find that expression of UAS.sd-
RNAi is sufficient to completely abolish Yki nuclear localisation in the follicle cell epithelium
of both early- and late-stage egg chambers (S3A and S3B Fig). We therefore characterised the
UAS.sd-RNAi phenotype in more detail and found that the resulting adult female animals are
completely sterile because of arrest of egg chamber development at stage 10 of oogenesis (S3B
Fig). When we examine such arrested stage 10 egg chambers, we observe that they lack suffi-
cient follicle cells to cover the surface of the egg chamber, leading to subsequent apoptosis of
germline cells (Dcp1-positive) (S3C Fig). These results show that strong Sd loss of function dis-
rupts follicle cell proliferation such that there are insufficient cells to cover the germline and
ensure its survival beyond stage 10 of oogenesis. This Sd loss-of-function phenotype confirms
graph shows quantification of the average number of mitotic cells (pH3+) per egg chamber in each of the genotypes
above (n> 10 egg chambers per genotype). For the Yki–RNA quantification, weaker phenotypes that still form
individual egg chambers were used to measure pH3+ cells per egg chamber. See supplementary file S1_Data.xlsx for
underlying data. D). Apoptosis, marked by Dcp1-positive cells, does not occur in follicle cell epithelia expressing Yki–
RNAi or Sd–RNAi but does occur in germline cells affected by insufficiency in follicle cell numbers upon expression of
Yki–RNAi. Follicle cell fate, marked by expression of Broad at stage 6 onward, is not affected by either Yki–RNAi or
Sd–RNAi. Scale bars approximately 10 μM. Dcp1, Drosophila Death Caspase 1; ex.lacZ, expanded.lacZ; Eya, Eyes
Absent; GFP, green fluorescent protein; IR, Inverted Repeat Hairpin RNAi; n/c, nuclear/cytoplasmic ratio; OvoD, Ovo
dominant; pH3+, phospho-Histone-H3–positive; RNAi, RNA interference; Sd, Scalloped; WT, wild type; Yki, Yorkie.
https://doi.org/10.1371/journal.pbio.3000509.g001
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a physiological requirement for regulation of the Hippo pathway during follicle cell prolifera-
tion in vivo.
Since both follicle cell proliferation and germline growth are known to depend profoundly
on nutritionally induced IIS [16, 17, 103, 104], we tested whether nutritional regulation of IIS
in the germline cells might affect Yki subcellular localisation in the overlying follicle cell epi-
thelium. We first compared the localisation of Yki–GFP in ovarioles from control (fed) adult
females with those subjected to nutrient restriction for 24 h. We found that nutrient restriction
caused a dramatic reduction in the nuclear localisation of Yki–GFP in follicle cells (Fig 2A).
To test whether the effects of nutrient restriction were mediated by IIS to the germline, we
induced null mutant clones of akt3 in the germline. We found that, as expected, cell growth is
dramatically impaired in akt3 mutant germline cells and that this leads to relocalisation of
Yki–GFP to the cytoplasm in the overlying follicle cell epithelium, which exhibits reduced cell
proliferation (Fig 2B). The effect of Akt on germline growth is mediated by TORC1 because
expression of UAS.TOR-RNAi in germline cells with the maternal tubulin.Gal4 driver reduces
germline cell growth and is sufficient to reduce mechanical stretching and nuclear localisation
of Yki–GFP in the surrounding follicle cell epithelium (S4 Fig). Thus, IIS acts on the germline
to drive cell growth and thus indirectly induces mechanical stretching of the follicular epithe-
lium and nuclear localisation of Yki in follicle cells.
We next tested whether IIS in the follicle cell epithelium itself affects Yki subcellular locali-
sation because this pathway has previously been shown to act via PI3K and PDK1 to promote
Yki activity in imaginal discs [90]. We sought to examine the role of the key downstream effec-
tor of these kinases, Akt, whose potential role was previously overlooked because RNAi of Akt
in S2 cells did not completely abolish the effect of insulin on Yki phosphorylation [90]. We
therefore induced mutant clones of akt3 in the follicle cell epithelium and found that Yki–GFP
relocalises to the cytoplasm in these clones, even following strong cellular stretching at late
stages of oogenesis (Fig 3A–3F).
PI3K–PDK1–Akt signalling acts by regulating the canonical Hippo pathway because an
Hpo dimerisation reporter, normally detectable only in columnar follicle cells and not in
stretched cells [88], is strongly up-regulated upon inhibition of PI3K or Akt or overexpression
of PTEN (Fig 4A–4C). The effect of Akt depends on canonical Hippo pathway signalling
because double mutant akt3 wtsX1 clones still exhibit nuclear Yki–GFP localisation, even in
columnar cells (Fig 4D). Furthermore, Yki nuclear localisation in highly stretched cells can be
inhibited by treatment with two different PDK1 inhibitors, BX-795 and BX-912, whose effects
are blocked by coexpression of UAS.Hpo-RNAi or UAS.Wts-RNAi (Fig 4E). The effect of Akt
in follicle cells is not mediated by TORC1 because expression of dominant-negative UAS.
TORTED or UAS.TOR-RNAi or induction of mutant clones for rheb does not prevent nuclear
localisation of Yki–GFP (Fig 4F and 4G). Together, the above results show that IIS, via PI3K–
PDK1–Akt, directly regulates the canonical Hippo pathway and is a prerequisite for nuclear
localisation of Yki in both proliferating early-stage follicle cells and flattening late-stage stretch
cells.
To confirm our findings in another Drosophila tissue, we examined the proliferating Dro-
sophila larval wing imaginal disc, particularly the wing pouch, where the Hippo pathway has
been shown to respond to gradients of Fat–Dachsous signalling [4–8] as well as physiological
mechanical inputs, Ajuba–Wts-mediated stress sensing in the columnar cells of the wing
pouch, and Hippo-pathway–mediated strain sensing in the overlying peripodial cells [89, 94]
(S5–S7 Figs). Since experimental manipulation of IIS has been reported to influence Hippo
pathway signalling via PI3K–PDK1 in the wing disc [90], we wondered whether physiological
changes in IIS might affect Yki nuclear localisation during wing development. Towards the
end of the third instar of larval development, feeding ceases, and larvae begin to wander out of
Physiological regulation of the Hippo pathway during tissue growth
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the food as they prepare to form pupae and undergo metamorphosis. Wing disc cell prolifera-
tion slows and subsequently arrests at this point, with final size determined by a combination
of reduced IIS from the brain and a surge of ecdysone signalling that triggers pupariation and
metamorphosis [21, 23, 105]. We tested whether this physiological change in IIS might regu-
late Yki–GFP as the wing disc slows and arrests proliferation at the end of the third instar. We
find that nuclear Yki–GFP localisation is prominent during early stages but is reduced by the
Fig 2. Insulin–PI3K–Akt signalling stimulates germline cell growth to drive mechanical stretching of follicle cells
and Yki–GFP nuclear localisation. A) Yki–GFP localises to the nucleus in early-stage ovarian follicle cells but
relocalises to the cytoplasm upon nutrient restriction of adult females for 24 h. Quantification of the nuclear/
cytoplasmic ratio is shown on the right (n> 30 per genotype, t test p< 0.05). Scale bars approximately 10 μM. See
supplementary file S1_Data.xlsx for underlying data. B) Yki–GFP localises to the nucleus in early-stage ovarian follicle
cells but relocalises to the cytoplasm upon induction of akt3 mutant clones in the germline, marked by the absence of
nlsRFP. Note that follicle cells are wild type. Scale bars approximately 10 μM. C) Surface views of akt3 mutant germline
clones from (B) allow quantification of n/c. Scale bars approximately 3 μM. See supplementary file S1_Data.xlsx for
underlying data. GFP, green fluorescent protein; nlsRFP, nuclear red fluorescent protein; n/c, nuclear/cytoplasmic
ratio; pH3, phospho-Histone H3; PI3K, phosphatidyl inositol-3-kinase; Yki, Yorkie.
https://doi.org/10.1371/journal.pbio.3000509.g002
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Fig 3. Insulin–PI3K–Akt signalling is required for nuclear localisation of Yki–GFP in the follicle cell epithelium.
A) Yki–GFP localisation to the nucleus is detectable in follicle cells at stage 4 of oogenesis. Scale bars approximately
10 μM. B) Yki–GFP localisation to the nucleus is weak or absent in follicle cells at stage 4 of oogenesis that are mutant
for akt3. Note that germline cells are wild type. Scale bars approximately 10 μM. C) Yki–GFP localisation to the nucleus
is weak or absent in follicle cells at stage 7 of oogenesis that are mutant for akt3. Scale bars approximately 10 μM. D)
Yki–GFP localisation to the nucleus is weak or absent in follicle cells at stage 10 of oogenesis that are mutant for akt3.
Scale bars approximately 10 μM. E) Yki–GFP localisation to the nucleus is weak or absent in follicle cells at stage 12 of
oogenesis that are mutant for akt3. Scale bars approximately 10 μM. F) Yki–GFP localisation to the nucleus is weak or
absent in follicle cells at stage 14 of oogenesis that are mutant for akt3. Scale bars approximately 10 μM. GFP, green
fluorescent protein; nlsRFP, nuclear red fluorescent protein; Yki, Yorkie.
https://doi.org/10.1371/journal.pbio.3000509.g003
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Fig 4. Insulin–PI3K–PDK1–Akt signalling to the follicle cell epithelium inhibits Hpo to drive nuclear Yki–GFP.
A) Expression of an Hpo KD BIFC sensor is detectable at the apical membrane of columnar follicle cells at stage 10 of
oogenesis and is dramatically up-regulated upon coexpression of a dominant-negative PI3K p60 subunit (UAS.p60). A
KA Hpo BIFC sensor is also dramatically up-regulated compared to the KD version. Scale bars approximately 10 μM.
B) Expression of PTEN up-regulates the KD Hpo BIFC sensor in columnar follicle cells at stage 10 of oogenesis. Scale
bars approximately 10 μM. C) Expression of Akt–RNAi up-regulates the KD Hpo BIFC sensor in columnar follicle
cells at stage 10 of oogenesis. D) Yki–GFP localisation to the nucleus is weak or absent in follicle cells at stage 10 of
oogenesis that are mutant for akt3 but is nuclear-localised in akt3 wtsX1 double mutant clones. Scale bars
approximately 10 μM. E) Yki–GFP localises to the nucleus in stretch cells at stage 10 of oogenesis. Inhibiting PDK1
activity acutely with BX-795 or BX-912 blocks Yki–GFP nuclear localisation in a manner that depends on the
canonical Hippo pathway kinases Hpo and Wts, whose knockdown with RNAi restores Yki–GFP nuclear localisation
even in the presence of PDK1 inhibitors. F) Yki–GFP localises to the nucleus even upon inhibition of TORC1 by
Physiological regulation of the Hippo pathway during tissue growth
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late third instar stage when cessation of larval feeding occurs (Fig 5A and S7 Fig). Reducing
Akt signalling by expression of akt–RNAi or subjecting early third instar larvae to nutrient
restriction for 24 h was sufficient to reduce Yki–GFP nuclear localisation (Fig 5B). Further-
more, the pattern of Yki nuclear localisation in early third instar wing discs can be maintained
in late third instar wing discs by expressing insulin receptor (UAS.InR) or constitutively active
forms of PI3K (UAS.dp110caax) or Akt (UAS.Akt-myr) in the posterior compartment with the
hedgehog.Gal4 (hh.Gal4) driver (Fig 5C). We confirm that hh.Gal4-driven manipulation of
PI3K–Akt signalling and manipulation of Yki activity in wing discs generates similar tissue
growth phenotypes in adult wings, illustrating the importance of cell proliferation control in
larval imaginal discs for determination of final tissue size (Fig 5D). These results support the
notion that the interplay of Fat–Dachsous signalling and mechanical cues with nutritionally
induced IIS, acting via PI3K–PDK1–Akt, controls Yki nuclear translocation to promote tissue
growth in the Drosophila wing.
A recent report suggested that IIS also acts via TOR to regulate Yki [96]. Interestingly, inhi-
bition of TOR caused a strong ectopic localisation of Yki to the nucleus, even in late third
instar imaginal discs [96]. We confirmed these findings with our Yki–GFP line, which strongly
accumulates in the nucleus when dominant-negative UAS.TORTED is expressed in the poste-
rior compartment of the wing disc (S8A Fig). The increase in nuclear Yki–GFP is due to dis-
ruption of the TORC1–Akt negative feedback loop [74] because the effects of UAS.TORTED are
reversed by treatment with PDK1 inhibitors (S8B Fig). Thus, IIS promotes cell proliferation in
the wing disc via PI3K–PDK1–Akt inhibition of the Hippo pathway and additionally promotes
cell growth via TORC1, which also provides negative-feedback–limit Akt signalling. Accord-
ingly, ectopic activation of IIS drives both cell growth and division, producing larger tissues
with larger cells [3, 106], while ectopic activation of Yki produces larger tissues composed of
increased numbers of normally sized cells [82].
We note that some differences exist between the spatiotemporal pattern of Yki–GFP locali-
sation and the pattern of the Yki reporter genes ex.lacZ and bantam.lacZ (ban.lacZ) in the
wing disc (Fig 6A). For example, the strong nuclear localisation of Yki–GFP at the Dorsal–
Ventral (D–V) boundary is not reflected in either ex.lacZ or ban.lacZ expression, and both tar-
get genes are instead repressed at the D–V boundary (Fig 6A). Recent results explain this dis-
crepancy because Notch signalling at the D–V boundary was found to potently repress the
ability of activated Yki to transcriptionally induce target gene expression in the wing disc
[107]. Thus, the combination of Fat–Dachsous signalling and mechanical and nutritional
inputs determines Yki nuclear localisation in the wing, while other signalling pathways,
such as Notch, can modulate the transcriptional output of Yki–Sd on specific target genes.
Nevertheless, the resulting pattern of ex.lacZ or ban.lacZ—low medially and high in a circum-
ferential pattern at the periphery (Fig 6A)—matches the pattern of Fat–Dachsous signalling
and mechanical stretching previously proposed to complement the action of compartment
boundary organisers [108, 109] and thus level out the rate of cell proliferation across the wing
pouch [110–114].
expression of dominant-negative TOR-TED or TOR-RNAi in stretch cells at stage 10 of oogenesis. G) Yki–GFP
localises to the nucleus even upon inhibition of TORC1 by induction of rheb mutant clones at stage 14 of oogenesis.
BIFC, bimolecular fluorescence complementation; DN, dominant-negative; GFP, green fluorescent protein;
Hpo, Hippo; inh., inhibited; IR, Inverted Repeat Hairpain RNAi; KA, kinase-active; KD, kinase-dead; PDK1,
phosphoinositide-dependent protein kinase 1; PI3K, phosphatidyl inositol-3-kinase; PTEN, phosphatase and tensin
homolog; Rheb, Ras-homolog enriched in the brain; RNAi, RNA interference; tj.Gal4, trafficjam.Gal4; TOR, Target of
Rapamycin; TORC1, TOR complex 1; UAS, Upstream activator sequence; Wts, Warts; Yki, Yorkie.
https://doi.org/10.1371/journal.pbio.3000509.g004
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Fig 5. Yki becomes nuclear in response to both mechanical inputs and nutritionally induced insulin/IGF-1 signals
in the developing wing. A) Yki–GFP localises to the nucleus in early second and third instar larval wing imaginal discs
in a pattern that closely resembles that of mechanical stress and strain (see also S7 Fig). Yki–GFP localises much less
strongly to the nucleus in late ‘wandering’ third instar larval wing imaginal discs. Note the cytoplasmic localisation in
the central region and weak nuclear localisation at the dorsal ventral boundary and at the periphery at late L3.
Quantification is shown on right (n> 10 per time point). Scale bars approximately 5 μM. See supplementary file
S1_Data.xlsx for underlying data. B) Silencing of akt expression by UAS.akt-RNAi hairpin transgene prevents nuclear
Yki–GFP localisation in the L2 wing disc. Reducing Akt signalling by nutrient restriction for 24 h also prevents nuclear
localisation of Yki–GFP at early L3. Quantification is shown on right (n> 10 per time point). Scale bars approximately
5 μM. See supplementary file S1_Data.xlsx for underlying data. C) Activating PI3K–Akt signalling by overexpression of
insulin receptor (hh.Gal4 UAS.InR), a membrane-targeted version of the PI3K catalytic subunit (hh.Gal4 UAS.
Physiological regulation of the Hippo pathway during tissue growth
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000509 October 15, 2019 11 / 31
To examine the mechanism by which Akt regulates the Hippo pathway in Drosophila, we
tested whether a conserved Akt consensus phosphorylation site first identified in the human
Hpo kinase homolog Mammalian Sterile 20 kinase (MST)2 in vitro [115–118] is required for
control of tissue growth in Drosophila. The Akt phosphorylation site (T132) is located two
amino acids downstream of the catalytic aspartate in the Hpo (and in human MST1/2) kinase
domains, suggesting that Akt phosphorylation of might directly inhibit Hpo kinase activity
(S9A–S9D Fig). A pan-Akt substrate phosphospecific antibody recognises the monomeric
form of the Hpo kinase but not the active dimer, suggesting that phosphorylation by Akt may
prevent dimerisation of Hpo (S9B Fig). We therefore tested whether mutation of the T132 resi-
due would cause ectopic activation of the Hpo kinase in vivo. Using a landing site system for
controlled expression of transgenes, we compared the effect of expressing wild-type Hpo ver-
sus phosphomutant HpoT132A in follicle cells. We find that wild-type Hpo mildly reduces the
number of follicle cells, while HpoT132A dramatically reduces follicle cell numbers, exposing
many gaps in the coverage of the germline (S9E Fig). Accordingly, Yki–GFP nuclear localisa-
tion is strongly inhibited by HpoT132A expression, even in stretched cells (S9E Fig). In the
wing, we find that phosphomutant HpoT132A dramatically inhibits tissue growth compared
with wild-type Hpo expression (S9F, S9G and S10 Figs). These results suggest that this highly
conserved Akt phosphorylation site in Hpo–MST1/2 kinases (S11 Fig) may be functional in
vivo, although Akt may also employ other mechanisms to regulate Hippo pathway signalling
to control cell proliferation and tissue growth.
Because the Hippo pathway appears to effectively integrate PI3K–Akt signalling with either
mechanical stress sensing (via Rho-kinase [Rok]–Ajuba–Wts) in the columnar cells of the
wing disc or mechanical strain sensing (via reduced Hpo kinase activation) in follicle cell epi-
thelium [89, 94], we sought to confirm that the Rok–Ajuba–Wts mechanism is indeed dispens-
able in follicle cells. Accordingly, mutant clones for rok2 or ajubaΔII induced in the follicle cell
epithelium (marked by absence of red fluorescent protein [RFP]) has no effect on nuclear loca-
lisation of Yki–GFP in mechanically stretched follicle cells (S12 Fig). These results confirm
that the Rok–Ajuba pathway is not required for regulation of the Hippo pathway by mechani-
cal strain, and thus, that the Hippo pathway uses distinct mechanisms to sense stress and strain
in Drosophila. Nevertheless, an input from PI3K–Akt is essential for Yki activation in response
to either stress or strain, regardless of the mechanisms involved.
In mammals, the skin epithelium is an example of a tissue in which both IIS via Akt [119–
125] and mechanically regulated YAP and Transcriptional Activator with a PDZ domain
(TAZ) [126–130] are known to promote keratinocyte cell proliferation, tissue regeneration
after wounding, and tumour formation. Previous work identified a key role for PI3K and
PDK1 in promoting nuclear localisation of YAP in skin keratinocytes [126] and other cell
types [131]. We now find that treatment with Akt inhibitor is sufficient to prevent YAP
nuclear localisation in keratinocytes, even when plated at a low density to induce mechanical
stimulation via integrin adhesions (Fig 7A). We further find that treatment of densely packed
keratinocytes (with cytoplasmic YAP) with IGF-1 is sufficient to promote YAP nuclear
dp110caax), or membrane-targeted Akt (hh.Gal4 UAS.akt-myr) in the P compartment is sufficient to maintain the
early pattern of Yki–GFP nuclear localisation in the posterior compartment of late third instar wing discs. Compare A
and P compartments. Scale bars approximately 5 μM. D) Adult wings showing similar tissue overgrowth and
undergrowth phenotypes in the posterior compartment when hh.Gal4 is used to silence expression of pten or hpo
(which causes P-compartment overgrowth) as well as akt and yki (which causes P-compartment undergrowth). A,
anterior; AEL, after egg laying; dp110caax, Drosophila p110-caax; GFP, green fluorescent protein; hh.Gal4, hedgehog.
Gal4; Hpo, Hippo; IGF-1, insulin-like growth factor 1; InR, insulin/IGF-1 receptor; n/c, nuclear/cytoplasmic ratio; P,
posterior; PI3K, phosphatidyl inositol-3-kinase; PTEN, phosphatase and tensin homolog; RNAi, RNA interference;
UAS, upstream activator sequence; Yki, Yorkie.
https://doi.org/10.1371/journal.pbio.3000509.g005
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Fig 6. Patterns of Sd–GFP, Yki–GFP, and Yki target genes in the wing disc and loss of nuclear Yki–GFP in akt3
clones. A) Wing imaginal discs at early, mid, and late L3 showing expression patterns for Sd–GFP, Yki–GFP and two
Yki target genes: ban.lacZ and ex.lacZ. Note the correlation between Yki–GFP nuclear localisation and its target
genes at early L3, at which both are elevated in a circumferential pattern. Note also that the pattern of lacZ (beta-
galactosidase) staining is maintained into late-stage L3 because of the perdurance of beta-galactosidase protein. Finally,
both ban.lacZ and ex.lacZ target genes are normally repressed at the D–V boundary by Notch signalling, which
prevents nuclear Yki–GFP from inducing them in this territory of the wing. Thus, only the circumferential activation
of Yki–GFP is normally functional in the wing pouch, consistent with its proposed role in wing growth. B) Late L3
wing imaginal disc peripodial epithelial cells are strongly stretched and retain nuclear Yki–GFP. Note that this nuclear
Yki–GFP localisation still depends on the low levels of Akt signalling occurring at this stage because the localisation
becomes cytoplasmic in akt3 mutant clones (marked by the absence of nlsRFP). ban.lacZ, bantam-lacZ; D–V, Dorsal–
Ventral; ex.lacZ, expanded.lacZ; GFP, green fluorescent protein; nlsRFP, nuclear red fluorescent protein; Sd, Scalloped;
Yki, Yorkie.
https://doi.org/10.1371/journal.pbio.3000509.g006
Physiological regulation of the Hippo pathway during tissue growth
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000509 October 15, 2019 13 / 31
Fig 7. YAP integrates mechanical cues with PI3K–Akt signalling to promote cell proliferation in mammalian
skin. A) Human skin keratinocytes (HaCaT) cultured in sparse conditions to induce nuclear localisation of YAP were
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localisation in all but the most crowded cells, similar to inhibition of the Hpo orthologs MST1/
2 (Fig 7B). Thus, activation of PI3K–Akt has a similar effect on YAP as inhibition of Hippo
pathway signalling in these cells. Finally, in mouse skin, activation of Akt by skin-specific dele-
tion of PTEN is sufficient to promote YAP nuclear localisation and tumour-like tissue over-
growth, similar to that induced by skin-specific expression of nuclear-localised YAP5SA (Fig
7C). Together, these results indicate that IIS via Akt inhibits the canonical Hippo pathway to
promote nuclear localisation of YAP and tissue growth in mammalian skin.
Discussion
Our results show that the Hippo pathway has a physiological function in integrating hormonal
IIS with mechanical inputs and polarity cues to control tissue growth in two different prolifer-
ating epithelia of Drosophila as well as in mammalian skin. Although manipulation of the
Hippo pathway was previously shown to strongly affect cell proliferation and tissue growth [4–
6], as well as to respond to the Fat–Dachsous planar polarity pathway [4–8], mechanical stress
[89, 91–94], and mechanical strain [88, 95], it was previously unclear whether the Hippo path-
way was also physiologically regulated by hormonal insulin/IGF-1 signals to control tissue
growth during development. Our findings support the view that Yki/YAP normally relocalise
to the nucleus to drive cell proliferation in epithelial cells subject to both mechanical stimuli
and growth factor signalling via the PI3K–PDK1–Akt pathway. Below, we discuss how the
Hippo pathway integrates these cues in different tissue types and different animal species. We
then consider how evolutionary changes in the structure of the epidermis between Drosophila
and mammals impact the mechanisms involved [8].
In the Drosophila ovarian follicle cell epithelium, our results suggest that growth of the
germline stretches the surrounding follicle cells to induce nuclear localisation Yki, which acti-
vates Sd-mediated transcription to promote cell proliferation (Figs 1 and 2). Note that previous
investigation with ex.lacZ failed to identify an effect of germline growth on follicle cell Yki
activity, most likely because of perdurance of the lacZ gene product, beta-galactosidase [16].
The primary mechanism of mechanotransduction in this tissue involves the canonical Hippo
pathway, which is activated by Crumbs (Crb)-mediated clustering of apical Hpo kinase con-
taining complexes to promote Hpo dimerisation and transactivation and inactivated by
mechanical strain to decluster the same complexes [88]. In addition, our results show that folli-
cle cells must receive an insulin/IGF-1 signal that activates PI3K–PDK1–Akt to inhibit the
Hpo kinase, possibly via direct phosphorylation on a conserved Akt phosphorylation motif or
via other mechanisms that are still to be elucidated (Figs 3 and 4; S9–S11 Figs). In the absence
of sufficient PI3K–PDK1–Akt signalling in follicle cells, the Hpo kinase becomes abnormally
active, and Yki is retained in the cytoplasm even following mechanical strain (Fig 4). We note
that PI3K–PDK1–Akt signalling directly affects Hpo kinase activity but that Hpo kinase activ-
ity itself promotes dimerisation because a kinase-active Hpo dimerisation sensor is much
treated with either control (DMSO) or Akt inhibitor (MK2206) at 1 μM for 4 hours prior to fixation and
immunostaining for YAP, which becomes cytoplasmic upon Akt inhibition. B) Human skin keratinocytes (HaCaT)
cultured in dense conditions to induce cytoplasmic localisation of YAP were treated with control (DMSO), IGF-1, or
MST1/2 kinase inhibitor (XMU-MP-1) for 4 hours prior to fixation and immunostaining for YAP, which becomes
nuclear upon IGF-1 activation or MST1/2 inhibition. C) Mouse skin from wild-type, skin-specific conditionally
induced PTEN knockout or skin-specific conditionally induced nuclear NLS–YAP–5SA–overexpressing animals were
immunostained for YAP (brown). Note similar nuclear localisation of YAP and tumour-like tissue overgrowth in both
PTEN knockout and NLS–YAP–5SA skin. IGF-1, insulin-like growth factor 1; inh., inhibited; MST, Mammalian Sterile
20 kinase; NLS, nuclear localisation signal; PI3K, phosphatidyl inositol-3-kinase; PTEN, phosphatase and tensin
homolog; YAP, Yes-associated protein.
https://doi.org/10.1371/journal.pbio.3000509.g007
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more strongly dimerised than the kinase-dead version [88]. Thus, the dimerisation and trans-
activation mechanism of the Hpo kinase enables it to integrate both mechanical inputs and
hormonal insulin/IGF-1 signals in follicle cells. We note that the Hippo pathway continuously
senses mechanical strain in the follicle cell epithelium [88] but only controls cell proliferation
during the early stages (1–7) of oogenesis (Figs 1–3), after which Notch receptor and ecdysone
receptor (EcR) activation terminates proliferation by inducing a switch to endoreplication
[132, 133].
During Drosophila wing disc growth, cessation of larval feeding in the late third instar stage
reduces IIS and leads to decreased Yki nuclear localisation as cell proliferation first slows and
then ultimately arrests upon ecdysone-induced metamorphosis (Fig 5A). Our findings confirm
previous work linking IIS via PI3K and PDK1 with regulation of the Hippo pathway in the
wing [90] and extend it by providing a molecular mechanism—Akt-mediated regulation of
Hpo signalling—and demonstrating the physiological significance of this mechanism in tissue
growth control (Figs 5A–5D, 6A and 6B). Our results confirm that nuclear localisation of Yki
occurs in both mechanically stressed cells (domains with high Rok and Myosin-II [Myo-II]
along the D–V boundary) and in mechanically strained cells (strongly flattened peripodial
cells), as well as cells with high Fat–Dachsous signalling (at the periphery of the wing pouch)
(Figs 5A–5C, 6A and 6B; S7 Fig). Stress sensing occurs via Rok and Myo-II, which are known
to promote localisation of the Wts/Large tumour suppressor (LATS) inhibitor Ajuba/LIM
domain 1 (LIMD1)/Thyroid receptor interacting protein 6 (TRIP6) to adherens junctions,
which promotes Yki activity in the wing disc [89, 94, 134–136] (S7B Fig). Strain sensing in
peripodial cells and also follicle cells occurs via a distinct mechanism involving dilution of api-
cal Hippo pathway components [88, 137], and thus, follicle cells do not require Rok or Ajuba
to activate Yki (S12 Fig). Note that the strong Ajuba-driven nuclear localisation of Yki along
the D–V boundary of the wing disc does not actually lead to pro-proliferative target gene acti-
vation because of antagonism by Notch signalling [107]. Thus, the Yki target gene bantam,
which, along with Myc, mediates much of the effect on Yki on cell proliferation [87, 138, 139],
is activated in a circumferential pattern at the periphery of the wing pouch and repressed
medially during the early larval stages (Fig 6A)—in agreement with proposed models for
mechanical stretch-induced proliferation in this tissue [110–114] and with gradients of Fat–
Dachsous signalling [4–8]. Note also that Ajuba-mediated Yki activation was recently pro-
posed to decline over time in the wing disc because of reduced mechanical stress and/or
increased compression of cells [89], and our finding that increased PI3K–Akt signalling
restores Yki nuclear localisation (Fig 5C and S7B Fig) suggests that integration of both
mechanics and hormonal input is necessary to explain the temporal regulation of Yki.
The role of Myc as a downstream target of PI3K–Akt and Yki is particularly interesting
because Myc not only stimulates cell proliferation and drives cell competition but also provides
positive feedback on PI3K–Akt signalling itself [140]. Thus, nutritional regulation of growth in
Drosophila involves insulin/IGF-1–mediated signalling via PI3K–Akt, which can stabilise the
Myc protein but also drive expression of the myc gene via activation of Yki–Sd (in the context
of sufficient mechanical input) to sustain a feed-forward loop that drives further signalling and
growth. Starvation-induced loss of IIS or insufficient mechanical input due to developmental
defects might thus rapidly slow growth until nutrition is located or normally coordinated
development is restored.
In mammalian skin, squamous epithelial cells lack a classical apical domain typical of
columnar epithelia. Instead, basal layer cells contact the underlying extracellular matrix via
basal integrin adhesions, which are important for stem cell proliferation [141–143] and to pro-
mote YAP/TAZ activation via multiple mechanisms, including activation of Focal Adhesion
Kinase (FAK) and Rous Sarcoma Virus Oncogene (Src)-family kinase signalling [7, 8, 93, 126].
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Src can directly phosphorylate YAP on three tyrosine residues to promote its activation [144]
and was also reported to inhibit the LATS1 kinase in mammals [145]. Integrin signalling can
also activate PAK1 to inhibit membrane association of the key upstream Hippo pathway acti-
vator Merlin/Neurofibromatosis2 (NF2) [146–153]. Notably, integrins are generally dispens-
able for regulation of the Hippo pathway in Drosophila species, which have a columnar
epidermis and can thus regulate Hippo pathway signalling via the apical domain as described
above [8]. Accordingly, Drosophila Yki lacks the tyrosine residues phosphorylated by Src in
mammalian YAP, and Drosophila Merlin lacks the PAK1 phosphorylation site from mamma-
lian Merlin/NF2.
Despite this divergence in mechanotransduction mechanisms between Drosophila and
mammals, the Akt site in Hpo is conserved in MST1/2 [115–118], and our results indicate that
integration of mechanical signalling and IIS is also a fundamentally conserved feature across
metazoa. As in Drosophila, growth-factor–induced PI3K signalling is necessary for nuclear
localisation of mammalian YAP [93, 126, 131], and our data show that this effect requires Akt
activity and that IGF-1 is sufficient to promote nuclear localisation of YAP in response to
mechanical stimulation in human keratinocytes (Fig 7). In mice, activation of PI3K–PDK1–
Akt in conditional knockout PTENflox/flox skin [154] also promotes YAP nuclear localisation
and skin proliferation, similar to conditionally induced expression of activated form of YAP
(nlsYAP5SA) (Fig 7), confirming that YAP acts as an integrator of mechanical cues and IIS via
PI3K–PDK1–Akt in skin cells both in culture and in vivo.
In conclusion, a key physiological function for the Hippo pathway is to integrate input
from epithelial cell polarity determinants, mechanical cues, and hormonal IIS to promote cell
proliferation and tissue growth in both Drosophila epithelia and mammalian skin. Although
mechanisms of mechanotransduction via the Hippo pathway differ in the monolayered colum-
nar epidermis of Drosophila versus the stratified squamous epidermis of mammals, growth fac-
tor signalling acts via a common PI3K–PDK1–Akt-mediated mechanism to inhibit the Hippo
pathway and thus promote tissue growth. Thus, the Hippo signalling pathway could be consid-
ered as one of the key effectors of Akt in tissue growth control, alongside inhibition of FOXO
and the classical inhibition of TSC1/2 to activate TORC1 (S13 Fig). Notably, our results show
that activation of Akt alone is not sufficient to activate Yki because some type of mechanical
stimulus is also necessary. In the absence of significant mechanical inputs, Akt acts primarily
via TORC1 and FOXO, and the postmitotic Drosophila pupal retina appears to exemplify this
mode of action—a phenomenon that helped distinguish and delineate PI3K–Akt and Hippo–
Yki as separate pathways in pioneering genetic screens. Nevertheless, the widespread coupling
of PI3K–Akt and Hippo pathway signalling in many tissues is potentially of major significance
for human cancer because activation of PI3K–Akt signalling (in PIK3CA or PTEN mutant
cells) causes formation of highly proliferative malignant tumours, while mutation of TSC1 or
TSC2 leads to formation of relatively benign tumours [75, 81]. Given the increasing evidence
for a potent role of YAP/TAZ in malignant tumours, future work should examine whether the
Hippo pathway might be the primary effector of PI3K–Akt signalling in human cancer and
thus a critical target for therapy.
Materials and methods
Ethics statement
All animal-regulated procedures were carried out according to Project License constraints
(PPL 70/7926) and United Kingdom Home Office guidelines and regulations. All experiments
were carried out in accordance with the UK Animal Scientific Procedures Act (1986). The
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Francis Crick Institute Animal Ethics committee was the responsible party for approving ani-
mal care and use under this project licence. The research did not involve human participants.
Drosophila genetics
Expression of UAS-driven transgenes in ovarian follicle cells was performed with the TJ.Gal4
driver and in wing imaginal disc cells with the hh.Gal4 driver, which is expressed in the poste-
rior compartment, or the nubbin.Gal4 (nub.Gal4) driver, which is expressed in the entire wing
pouch. Depletion of Yki in the follicle cell epithelium was driven by a strong UAS.Yki-RNAi
(BL34067) using the TJ.Gal4 driver. Depletion of Sd in the follicle cell epithelium was driven
by a strong UAS.Sd-RNAi (VDRC KK101497) using the TJ.Gal4 driver. Fly crosses were kept
at a temperature of 25 ˚C. Ovaries were dissected and immunostained from adult females 4
days after eclosion. Larvae were dissected at stage L3 of development. After dissection, samples
were fixed in 4% paraformaldehyde and processed for imaging.
CRISPR/Cas9 genome editing was used to tag the C-terminus of Yki with eGFP. 100 ng/μl
of guide RNA plasmid (pCFD3, Addgene 49410, encoding the gRNA 50-TCAGGTTTGTGG-
GAAGACGG-30; Addgene, Cambridge, MA, USA), plus 500 ng/μl of a homologous recombi-
nation repair template plasmid, were coinjected into nos-Cas9 embryos. The repair template
contained 4.5 kb genomic DNA from the Yki locus (centred around the stop codon), with
eGFP inserted in-frame after the final amino acid of Yki and before its stop codon. The gRNA
target sequence in the repair template was mutagenised to prevent recutting of correctly tar-
geted alleles. The resulting knockin allele is homozygous viable [88].
Drosophila genotypes
The Drosophila genotypes used were as follows:
Fig 1A: exlacZ/CyO
Fig 1B: Yki:GFP
Fig 1C: wiso
TJ.Gal4;UAS.Yki-RNAi BL34067/+
TJ.Gal4;UAS.Sd-RNAi KK101497/+
Fig 1D: wiso
TJ.Gal4/+;UAS.Yki-RNAi BL34067/+
TJ.Gal4/+;UAS.Sd-RNAi KK101497/+
Fig 2A: Yki:GFP
Fig 2B: hsflp; Yki:GFP;FRT82 akt3/FRT82 nlsRFP
Fig 2C: hsflp; Yki:GFP; FRT82 akt3/FRT82 nlsRFP
Fig 3A–3F: hsflp; Yki:GFP; FRT82 akt3/FRT82 nlsRFP
Fig 4A: TJ.Gal4;UAS.HippoKDVenusC;UAS.HippoKDVenusN
TJ.Gal4;UAS.HippoKDVenusC;UAS.HippoKDVenusN/UAS.DN–PI3K (p60)
TJ.Gal4;UAS.HippoVenusC;UAS.HippoVenusN
Fig 4B: TJ.Gal4;UAS.HippoKDVenusC;UAS.HippoKDVenusN/UAS.PTEN
Fig 4C: TJ.Gal4;UAS.HippoKDVenusC;UAS.HippoKDVenusN/UAS.Akt–RNAi
Fig 4D: hsflp; FRT82 akt3/FRT82 nlsRFP
hsflp; FRT82 akt3 wtsX1/FRT82 nlsRFP
Fig 4E: TJ.Gal4/Yki:GFP;
TJ.Gal4/Yki:GFP;UAS.Hpo–RNAi/+
TJ.Gal4/Yki:GFP;UAS.Wts–RNAi/+
Fig 4F: TJ.Gal4/Yki:GFP;UAS.TORTED/+
(Continued )
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(Continued)
TJ.Gal4/Yki:GFP;UAS.TOR–RNAi/+
Fig 4G: hsflp; Yki:GFP;FRT82 rheb/FRT82 nlsRFP
Fig 5A: Yki:GFP
Fig 5B: ms1096.Gal4/UAS.akt-RNAi;Yki:GFP
Fig 5C: Yki:GFP;hh.Gal4/UAS.InR
Yki:GFP/UAS.dp110caax;hh.Gal4/+
Yki:GFP/UAS.Akt-myr;hh.Gal4/+
Fig 5D: hh.Gal4/+
UAS.pten-RNAi;hh.Gal4/+
UAS.hpo-RNAi;hh.Gal4/+
UAS.akt-RNAi;hh.Gal4/+
UAS.yki-RNAi;hh.Gal4/+
Fig 6A: Sd:GFP
Yki:GFP
ban.lacZ
Fig 6B: hsflp;Yki:GFP;FRT82 akt3/FRT82 nlsRFP
Drosophila immunohistochemistry
Ovaries and imaginal discs were dissected in PBS, fixed for 20 mins in 4% paraformaldehyde
in PBS, washed for 30 minutes in PBS/0.1% Triton X-100 (PBST), and blocked for 15 minutes
in 5% normal goat serum/PBST (PBST/NGS). Primary antibodies were diluted in PBST/NGS,
and samples were incubated overnight at 4 ˚C.
The primary antibodies used were mouse anti-βgal (1:500; Promega, Madison, WI, USA),
FITC-conjugated anti-GFP (1:400; Abcam, Cambridge, UK), mouse anti-Eya (1:250, DSHB),
and mouse anti-Armadillo (1:100, Developmental Studies Hybrid Bank [DSHB], University of
Iowa, Iowa City, IA, USA).
Secondary antibodies (all from Molecular Probes, Invitrogen, Carlsbad, CA, USA) were
used at 1:500 for 2–4 hours prior to multiple washes in PBST and staining with DAPI at 1 μg/
ml for 10–30 min prior to mounting on slides in Vectashield (Vector Laboratories, Burlin-
game, CA, USA).
Drosophila image acquisition
Confocal images were taken with a Leica SP5 confocal microscope (Wetzlar, Germany) using
20× and 40× oil immersion objectives and processed with Adobe Photoshop and Fiji. Either
optical cross-sections through the middle of the different tissues or the top focal plane are
shown in all figures. Pictures of the adult wings mounted in Hoyer’s medium were taken on a
Zeiss Axioplan 2 Imaging Microscope (Oberkochen, Germany).
Cell culture
Human HaCAT cells (Francis Crick Institute cell services) were grown in DMEM (Gibco
41966; Gaithersburg, MD, USA) with 10% FCS and penicillin/streptomycin. All cells are sub-
ject to mycoplasma testing. Cells were treated with the Akt inhibitor MK2206 or the MST1/2
inhibitor XMU-MP-1 for 4 hours before being fixed with 4% PFA for 15 minutes before
immunostaining.
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Cell culture antibodies, image acquisition, and quantification
The primary antibodies used were mouse YAP (Santa Cruz sc-101199) 1:100. Secondary anti-
bodies were from Invitrogen and used at 1:500 for 2 hours at room temperature along with
DAPI. Cell culture samples were imaged with a Leica SP5 confocal microscope using a 63× oil
immersion objective and processed using Adobe Photoshop. Cells were assessed over three
independent experiments, counting 200–300 cells per condition.
Mouse experiments
Conditional activation of Cre recombinase in adult epidermis. Tamoxifen (20 mg/ml in con oil;
Sigma-Aldrich, St. Louis, MO, USA) was injected intraperitoneally (IP) (5 μl/g body weight)
for 5 consecutive days into 8- to 16-week–old control animals or transgenic animals carrying
K5–CreERt Yap R26–YAP5SA–NLS to induce YAP5SA–NLS expression and analysed for
LacZ (lineage tracer) expression by immunohistochemistry from 3 days thereafter [127]. Simi-
lar experiments were performed for the PTEN flox/flox conditional knockout skin, as
described in [154].
Immunohistochemistry
Mouse skin samples were harvested and fixed in neutral-buffered formaldehyde 10% vol/vol
(Sigma-Aldrich) and then embedded in paraffin in a head-to-tail orientation. The tissues were
processed, embedded, and sectioned at 4 μm and used for haematoxylin–eosin staining and
immunohistochemistry. Sections were dewaxed in xylene and dehydrated by passage through
graded alcohols to water. If required for antigen retrieval, sections were microwaved in citrate
buffer (pH 6) for 15 minutes and then transferred to PBS. Endogenous peroxidase was blocked
using 1.6% hydrogen peroxide in PBS for 10 minutes, followed by washing in distilled water.
Species-specific blocking serum (diluted to 10% in 1% BSA) was used to block nonspecific
staining in the tissue for 30 minutes. Slides were incubated with primary antibody diluted to
1:100 in 1% BSA for 1 hour at room temperature. Sections were washed in PBS prior to apply-
ing the appropriate biotinylated secondary antibody for 45 min at room temperature. Sections
were then washed in PBS and then incubated in ABC (Vector Laboratories PK-6100) for 30
minutes. Following washing in PBS, DAB solution was applied for 2–5 minutes with develop-
ment of the colour reaction being monitored microscopically. Slides were washed in tap water,
stained with a light haematoxylin, dehydrated, cleared, and then mounted. Antibodies used for
IHC were YAP Cell signalling (14074) 1/400 O/N. Images were acquired with a Zeiss light
microscope using 40× and 20× objectives.
Supporting information
S1 Fig. Yki–Venus localises to the nucleus in the mechanically stretched cells of the follicle
cell epithelium during Drosophila oogenesis. A) A Yki–Venus knockin line behaves identi-
cally to the Yki–GFP line. Note nuclear localisation in follicle cells at early stages of oogenesis.
DAPI (blue) marks nuclei. B) At stage 10 of oogenesis, the Yki–Venus knockin line again
behaves identically to the Yki–GFP line, showing nuclear localisation in stretch cells (anterior,
left) but not columnar cells that contact the oocyte (posterior, right). GFP, green fluorescent
protein; Yki, Yorkie.
(TIFF)
S2 Fig. Sd localises constitutively to the nucleus in the follicle cell epithelium throughout
Drosophila oogenesis. A) An Sd–GFP knockin line localises to the nucleus in all follicle cells
at early stages of oogenesis. F-actin is costained in red. B) An Sd–GFP knockin line localises to
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the nucleus in all follicle cells at stages 6–10 of oogenesis. F-actin is costained in red. DAPI
marks nuclei in blue. C) An Sd–GFP knockin line localises to the nucleus in all follicle cells at
stage 14 of oogenesis. DAPI marks nuclei in blue. GFP, green fluorescent protein; Sd, Scal-
loped.
(TIFF)
S3 Fig. Loss of Sd prevents Yki nuclear localisation and causes arrest of egg chamber devel-
opment at stage 10. A) Expression of Sd–RNAi prevents nuclear localisation of Yki–GFP in
early-stage egg chambers. Compare with Fig 1B. B) Expression of Sd–RNAi prevents nuclear
localisation of Yki–GFP in late-stage egg chambers, including stretch cells at stage 10. C) Apo-
ptosis, marked by Dcp1-positive cells, occurs in stage 10 germline cells affected by insuffi-
ciency in follicle cell numbers upon expression of Sd–RNAi. The Sd loss-of-function
phenotype is a weaker version of the Yki loss-of-function phenotype; compare with Fig 1D.
Dcp1, Drosophila Death Caspase 1; GFP, green fluorescent protein; RNAi, RNA interference;
Sd, Scalloped; Yki, Yorkie.
(TIFF)
S4 Fig. Tor-driven germline cell growth is required for flattening of ‘stretch cells’ at stage 9
of oogenesis at which Yki becomes strongly nuclear. A) Yki–GFP localises to the nucleus in
stretch cells and to the cytoplasm in columnar cells of the follicular epithelium at stage 9 of
oogenesis. DAPI marks nuclei in blue. F-actin is costained in red. B) Yki–GFP localises to the
cytoplasm in all cells when germline growth is arrested by silencing of Tor by expression of
UAS.tor-RNAi specifically in germline cells with the maternal tub.Gal4 driver line. Note failure
of stretch cells to become flattened in this stage 9 egg chamber. C) Yki–GFP localises to the
cytoplasm in all cells when germline growth is arrested by silencing of Tor by expression of
UAS.tor-RNAi specifically in germline cells with the maternal tub.Gal4 driver line. Note failure
of stretch cells to become flattened in this stage 8 egg chamber. GFP, green fluorescent protein;
RNAi, RNA interference; TOR, Target of Rapamycin; tub.Gal4, tubulin.Gal4; UAS, Upstream
activator sequence; Yki, Yorkie.
(TIFF)
S5 Fig. Sd–GFP expression pattern in imaginal discs. A) Yki–GFP expression is shown in
the wing disc proper, the wing disc peripodial epithelium, the eye disc, the eye disc peripodial
epithelium, the leg disc, and the haltere disc. GFP, green fluorescent protein; Sd, Scalloped;
Yki, Yorkie.
(TIFF)
S6 Fig. Yki–GFP expression pattern in eye and leg imaginal discs. A) Eye imaginal discs at
early, mid, and late third instar (L3) stages, showing frequent nuclear Yki–GFP in early stages
and predominantly cytoplasmic Yki–GFP at late stages. Note the strong nuclear Yki–GFP in
the flattened cells of the peripodial epithelium at the periphery. B) Leg imaginal discs at early,
mid, and late third instar (L3) stages, showing frequent nuclear Yki–GFP in early stages and
predominantly cytoplasmic Yki–GFP at late stages. Note the strong nuclear Yki–GFP in the
flattened cells of the peripodial epithelium at the periphery. GFP, green fluorescent protein;
Yki, Yorkie.
(TIFF)
S7 Fig. Yki–GFP nuclear localisation reflects apical domain stretching (strain) as well as
the pattern of Rok-–GFP/Myo-II–GFP/Jub accumulation (stress) at the apical domain in
the wing pouch. A) Early, mid, and late third larval instar (L3) wing imaginal discs stained for
Yki-–GFP knockin, endogenously expressed Myo-II/Sqh–GFP, and Rok–GFP expressed with
Physiological regulation of the Hippo pathway during tissue growth
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000509 October 15, 2019 21 / 31
nub.Gal4-driven UAS.Rok–GFP. Note correlation between Yki–GFP nuclear localisation and
the pattern of mechanical stress and strain indicated by Myo-II/Sqh–GFP or Rok–GFP. B)
Late-stage third larval instar (L3) wing imaginal disc immunostained for Jub and phospho-Src,
both of which accumulate a junction in response to mechanical stress but not strain. GFP,
green fluorescent protein; Jub, Ajuba; Myo-II, Myosin-II; nub.Gal4, nubbin.Gal4; Rok, Rho-
kinase; Sqh, Spaghetti Squash; Src, Rous Sarcoma Virus Oncogene; Yki, Yorkie.
(TIFF)
S8 Fig. Expression of a dominant-negative form of tor (torTED) in the posterior compart-
ment of the wing disc increases Yki nuclear translocation via feedback effects on PDK1–
Akt activity. A) Upon inhibition of TOR activity by expression of hh.Gal4 UAS.torTED, there
is an increase in Yki nuclear translocation in a group of cells. B) The UAS.torTED-driven
nuclear translocation of Yki is inhibited by the PDK1 kinase inhibitor BX-795, indicating that
TOR activity normally drives a negative feedback loop to inhibit PI3K–PDK1–Akt signalling,
disruption of which leads to PDK1–Akt hyperactivation and Yki nuclear translocation in the
wing. hh.Gal4, hedgehog.Gal4; PDK1, phosphoinositide-dependent kinase 1; PI3K, phosphati-
dyl inositol-3-kinase; TOR, Target of Rapamycin; UAS, Upstream activator sequence; Yki,
Yorkie.
(TIFF)
S9 Fig. An Akt phosphorylation site (T132) modulates Hpo kinase activity in vivo.
A) Sequence of the Hpo kinase domain showing location of the catalytic aspartate residue adja-
cent to the Akt phosphorylation site. B) Conservation of the Akt phosphorylation site motif
between Drosophila Hpo and human MST1/2, but not in the non-Hippo pathway kinases
MST3/4. A pan-Akt substrate phosphospecific antibody recognises monomeric immunopre-
cipitated Hpo kinase but not the dimeric form, suggesting that Akt phosphorylation may
inhibit Hpo dimerisation in S2 cells. C) Diagram of the Hpo kinase structure showing the sur-
face accessibility of the Akt phosphorylation site adjacent to the ATP binding cleft. D) Close-
up of the loop connecting the Akt phosphorylation site with the catalytic aspartate residue.
E) Expression of wild-type Hpo from a third chromosome landing site causes a mild reduction
in the number of follicle cells, with occasional gaps in the epithelium(�). Expression of phos-
phomutant HpoT132A from the same landing site causes a strong reduction in the number of
follicle cells, with frequent gaps in the epithelium(�) and a failure of posterior cells to colum-
narise (arrow). Yki–GFP remains cytoplasmic, even in highly stretched cells, upon expression
of HpoT132A. F) Expression of wild-type Hpo from a third chromosome landing site causes a
mild reduction in wing size, while expression of phosphomutant HpoT132 from the same
landing site causes a dramatic reduction in wing size. G) Quantification of F. See supplemen-
tary file S1_Data.xlsx for underlying data. GFP, green fluorescent protein; Hpo, Hippo; MST,
Mammalian Sterile 20 kinase; Yki, Yorkie.
(TIFF)
S10 Fig. Genetic epistasis between overexpressed active Akt and overexpressed Hpo
kinases. A) Wing-specific nub.Gal4-driven expression of UAS.myr–Akt induces wing over-
growth. Overexpression of strongly active UAS.hpoT132A prevents wing growth and also pre-
vents coexpressed UAS.myr–Akt from driving growth. B) Quantification of wing area from A.
See supplementary file S1_Data.xlsx for underlying data. Hpo, Hippo; nub.Gal4, nubbin.Gal4;
UAS, Upstream activator sequence.
(TIFF)
S11 Fig. Conservation of the Akt site in MST1/2 and Hpo across metazoa. Alignment of the
Akt phosphorylation consensus motif in MST1/2 but not MST3/4 orthologs across metazoans.
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Hpo, Hippo; MST, Mammalian Sterile 20 kinase.
(TIFF)
S12 Fig. The Rok/Jub mechanical stress sensing pathway is not required for Yki–GFP
nuclear localisation in stretched follicle cells. A) No effect on nuclear Yki–GFP localisation
in Rok mutant (rok2) clones, marked by absence of nlsRFP in mechanically stretched follicle
cells. B) No effect on nuclear Yki–GFP localisation in Jub mutant (jubΔ2) clones, marked by
absence of nlsRFP in mechanically stretched follicle cells. Inset shows surface views of early
stage 4 egg chamber. GFP, green fluorescent protein; Jub, Ajuba; nlsRFP, nuclear red fluores-
cent protein; Rok, Rho-kinase; Yki, Yorkie.
(TIFF)
S13 Fig. Schematic diagram of Hippo signalling integrating PI3K-–Akt, mechanical, and
polarity cues.
(TIFF)
S1 Data. Data underlying Figs 1A, 1B, 2A, 2C, 5A and 5B, S9G and S10B Figs.
(XLSX)
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